Acumen Pharmaceuticals (ABOS) Shareholder's Equity (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 595,226.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 31.42 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Acumen Pharmaceuticals | 164.37 Mn | 35.97 Mn | - | 87.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 87.48 Mn |
| Dec 31, 2025 | 70.43 Mn |
| Sep 30, 2025 | 93.17 Mn |
| Jun 30, 2025 | 117.08 Mn |
| Mar 31, 2025 | 155.52 Mn |
| Dec 31, 2024 | 181.82 Mn |
| Sep 30, 2024 | 217.20 Mn |
| Jun 30, 2024 | 243.95 Mn |
| Mar 31, 2024 | 262.03 Mn |
| Dec 31, 2023 | 266.97 Mn |
| Sep 30, 2023 | 280.27 Mn |
| Jun 30, 2023 | 168.87 Mn |
| Mar 31, 2023 | 179.09 Mn |
| Dec 31, 2022 | 188.78 Mn |
| Sep 30, 2022 | 196.65 Mn |
| Jun 30, 2022 | 206.52 Mn |
| Mar 31, 2022 | 216.09 Mn |
| Dec 31, 2021 | 225.18 Mn |
| Sep 30, 2021 | 233.36 Mn |
| Jun 30, 2021 | -106.08 Mn |
| Mar 31, 2021 | -45.46 Mn |
| Dec 31, 2020 | -18.59 Mn |
| Sep 30, 2020 | -17.87 Mn |
| Jun 30, 2020 | -15.42 Mn |